Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
1,812%
upside
3 price targets
|
0
%
|
|
|
|
1,570%
upside
4 price targets
|
0
%
|
|
|
|
889%
upside
4 price targets
|
0
%
|
|
|
|
ATYR
4
aTyr Pharma
ATYR
$66.6M
|
831%
upside
3 price targets
|
0
%
|
|
|
768%
upside
3 price targets
|
0
%
|
|
|
|
625%
upside
5 price targets
|
0
%
|
|
|
|
561%
upside
3 price targets
|
0
%
|
|
|
|
481%
upside
3 price targets
|
0
%
|
|
|
|
456%
upside
3 price targets
|
0
%
|
|
|
|
446%
upside
3 price targets
|
0
%
|
|
|
11
Arcturus Therapeutics
ARCT
$193M
|
360%
upside
6 price targets
|
0
%
|
|
|
338%
upside
4 price targets
|
0
%
|
|
|
|
329%
upside
3 price targets
|
0
%
|
|
|
|
312%
upside
3 price targets
|
0
%
|
|
|
|
292%
upside
3 price targets
|
0
%
|
|
|
|
243%
upside
4 price targets
|
0
%
|
|
|
|
239%
upside
3 price targets
|
0
%
|
|
|
|
229%
upside
3 price targets
|
0
%
|
|
|
|
210%
upside
4 price targets
|
0
%
|
|
|
|
185%
upside
4 price targets
|
0
%
|
|
|
|
181%
upside
3 price targets
|
0
%
|
|
|
|
175%
upside
3 price targets
|
0
%
|
|
|
|
173%
upside
4 price targets
|
0
%
|
|
|
|
168%
upside
4 price targets
|
0
%
|
|
|
|
167%
upside
6 price targets
|
0
%
|
|